About CELLULARIS
We are a deep-tech company that provides state-of-the-art 3D of human disease for the discovery of new biological targets and screening candidate therapies in the preclinical phase.
Cellularis’ leverages on deep expertise in bioengineering, cell-technologies, 3D biofabrication, and biochemistry, providing living screening platforms and expert advice for preclinical drug discovery and development pipelines.
Our Goals
Optimizing Clinical Trials
The company’s intent is to provide greater precision, efficiency, and cost-effectiveness in the drug development pipeline via 3D disease models in vitro that deliver a better correlation with clinical trials and patient therapeutic outcomes.
Protect and Improve Animal Welfare
Cellularis’ ambition lies in providing a viable alternative to animal testing and reducing its use in clinical trials, being fully in line with current regulatory agencies’ guidelines (FDA Advancement Act 2022).
Build Partnerships
We seek to work closely with pharmaceutical companies, research centers, and healthcare providers in developing pharmaceuticals and new in vitro technologies of disease models.
Our Team
We are delighted to introduce you to the exceptional people who drive Cellularis forward.
Guided by visionary leaders and driven by the dedication of skilled professionals, our team embodies the values of collaboration, excellence and perseverance. With a wealth of expertise spanning multiple disciplines, our diverse team play a pivotal role in our mission, combining their distinct talents, viewpoints and ingenuity to fuel innovation.
Get to know the team behind Cellularis Biomodels.
Executive Management
Our Executive Management team is responsible for the company’s strategic direction and daily operations. With complementary expertise spanning biotechnology, finance, and technology, our leadership is committed to advancing innovative cellular biomodels that transform preclinical research.
Research Team
Our research team is the engine of innovation at Cellularis Biomodels. Comprising PhD researchers, laboratory technicians, and research assistants, they work collaboratively to develop and validate our 3D disease models, ensuring scientific rigor and translating cutting-edge research into practical solutions for drug discovery.
